Peptidomimetic-based antibody surrogate for HER2
Inhibition of human epidermal growth factor receptor 2 mediated cell signaling pathway is an important therapeutic strategy for HER2-positive cancers. Although monoclonal antibodies are currently used as marketed drugs, their large molecular weight, high cost of production and susceptibility to prot...
Main Authors: | Mengmeng Zheng, Chunpu Li, Mi Zhou, Ru Jia, Fengyu She, Lulu Wei, Feng Cheng, Qi Li, Jianfeng Cai, Yan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383521001556 |
Similar Items
-
Development of Bioactive Peptidomimetics
by: She, Fengyu
Published: (2018) -
Promising Antibiofilm Activity of Peptidomimetics
by: Rafael Gomes Von Borowski, et al.
Published: (2018-09-01) -
Interrogation of Protein Function with Peptidomimetics
by: Bolarinwa, Olapeju
Published: (2018) -
Structure Based Antibody-Like Peptidomimetics
by: Mark I. Greene, et al.
Published: (2012-02-01) -
Structure-based Design, Synthesis and Applications of a New Class of Peptidomimetics: <em>'Y</em>-AA Peptides and Their Derivatives
by: Su, Ma
Published: (2018)